CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-08 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −14,625 | $478.58 | $7.0M | 0 |
| 2025-12-08 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +7,875 | $478.58 | $3.8M | 7,875 |
| 2025-12-08 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −7,875 | $478.58 | $3.8M | 0 |
| 2025-12-08 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Stock Options 10b5-1 | −14,625 | 155,625 | ||
| 2025-12-08 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Stock Options 10b5-1 | −7,875 | 14,065 | ||
| 2025-12-08 | EDGEMOND JAMES CFO AND TREASURER | Exercise or conversion 10b5-1 | +21,000 | $146.03 | $3.1M | 29,142 |
| 2025-12-08 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −400 | $475.08 | $190K | 28,742 |
| 2025-12-08 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −2,957 | $476.17 | $1.4M | 25,785 |
| 2025-12-08 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −6,529 | $477.18 | $3.1M | 19,256 |
| 2025-12-08 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −3,295 | $477.97 | $1.6M | 15,961 |
| 2025-12-08 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −3,139 | $479.16 | $1.5M | 12,822 |
| 2025-12-08 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,559 | $480.03 | $748K | 11,263 |
| 2025-12-08 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −477 | $481.22 | $230K | 10,786 |
| 2025-12-08 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −523 | $482.22 | $252K | 10,263 |
| 2025-12-08 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −742 | $483.29 | $359K | 9,521 |
| 2025-12-08 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −739 | $484.51 | $358K | 8,782 |
| 2025-12-08 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −120 | $484.85 | $58K | 8,662 |
| 2025-12-08 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −520 | $486.71 | $253K | 8,142 |
| 2025-12-08 | EDGEMOND JAMES CFO AND TREASURER | Exercise or conversion · Stock Option 10b5-1 | −21,000 | 3,517 | ||
| 2025-12-08 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
Page 173 of 214 · 4,273 trades